Xtl Biopharmaceuticals (XTLB) Times Interest Earned (2009 - 2024)
Xtl Biopharmaceuticals (XTLB) posted quarterly Times Interest Earned of -$7.52 for Q4 2024, up 64.26% on a QoQ basis from -$21.03 in Q3 2024.
Xtl Biopharmaceuticals (XTLB) Times Interest Earned (2009 - 2024) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Times Interest Earned for 13 consecutive years, with -$7.52 the latest figure, recorded in Q4 2024.
- Quarterly Times Interest Earned changed N/A year-over-year to -$7.52 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$4.78 (down 153.16% YoY) and the FY2025 annual result came in at -$6.35, up 8.29% from the prior year.
- Times Interest Earned improved to -$7.52 in Q4 2024 per XTLB's latest filing, from -$21.03 in the prior quarter.
- Over the last five years, Times Interest Earned for XTLB reached as high as $59.31 in Q2 2024 and fell as low as -$553.0 in Q3 2022.
- A 3-year average of -$50.7 and a median of -$1.21 in 2024 frame the typical range for Times Interest Earned.
- The largest YoY upside for Times Interest Earned was 1064.32% in 2024 against a maximum downside of 208.94% in 2024.
- Year by year, Times Interest Earned stood at -$553.0 in 2022, then soared by 93.68% to -$34.96 in 2023, then soared by 78.5% to -$7.52 in 2024.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$7.52, -$21.03, and $59.31 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Xtl Biopharmaceuticals | 2.58 Bn | 2.58 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -7.52 |
| Sep 30, 2024 | -21.03 |
| Jun 30, 2024 | 59.31 |
| Mar 31, 2024 | -10.94 |
| Sep 30, 2023 | -34.96 |
| Jun 30, 2023 | 5.09 |
| Mar 31, 2023 | 10.04 |
| Sep 30, 2022 | -553.00 |
| Jun 30, 2022 | 18.36 |
| Mar 31, 2022 | 27.67 |
| Dec 31, 2018 | -3.40 |
| Sep 30, 2018 | 477.00 |
| Jun 30, 2018 | -8.36 |
| Mar 31, 2018 | -33.00 |
| Dec 31, 2017 | -3.20 |
| Sep 30, 2017 | 0.15 |
| Jun 30, 2017 | -1.15 |
| Mar 31, 2017 | 0.49 |
| Dec 31, 2016 | -91.77 |
| Sep 30, 2016 | 300.00 |